Case Studies

How We Solve Complex
Pharmaceutical Sourcing Cases

Six anonymised case studies illustrating the kinds of supply scenarios Euro Biom routinely handles for hospitals, ministries of health, NGOs and clinical trial sponsors. Every capability described maps to a documented service we operate under MHRA WDA(H) 59239.

MHRA WDA Licence No. WDA(H) 59239
Submit Your Case About Euro Biom

⚡ Same-day response · Mon-Fri 09:00-18:00 · WhatsApp us

Why Anonymised
A note on confidentiality.

Pharmaceutical procurement is commercially confidential. Hospitals, ministries of health and NGOs rarely authorise the public naming of specific patient supply, tender or programme details, particularly where named-patient import pathways or locally unregistered medicines are involved.

Each case below is a composite based on the service lines Euro Biom operates under WDA(H) 59239. Regulatory frameworks, turnaround times, documentation and logistics arrangements described are the same arrangements we use in real engagements.

For active procurement or tender qualification, we can provide direct references from existing customers under appropriate confidentiality arrangements. Contact us to arrange this as part of due diligence.

40+
Countries served across GCC, MENA, Africa, Asia and Europe
WDA(H)
MHRA Wholesale Dealer Authorisation, licence WDA(H) 59239
Same-day
Response to every enquiry. Emergency cases within 4 hours
2-8°C
Cold chain handling for temperature-sensitive UK-licensed medicines
Six Cases
The kinds of work we do.

Each case shows the situation, our approach, and the outcome. Service lines link to the relevant pages on our site.

GCC · Saudi Arabia Named-Patient Import

Paediatric oncology agent for an urgent named-patient import case

Situation

A major teaching hospital required a paediatric oncology agent for an individual patient. The product was not registered with the SFDA. Local distributors could not source within the clinical timeframe.

Approach

WDA(H)-authorised import direct from the UK manufacturer. Full Special Access pathway documentation prepared for SFDA. End-to-end cold chain validated through Heathrow.

Outcome

Sourced and shipped within 72 hours. Certificate of Analysis, batch records and continuous temperature log provided on delivery. Supply pathway compatible with NUPCO 2026 named patient exemptions.

🕑 ~72 hours, end to end Service used →
North Africa · Egypt Drug Shortage Emergency

Carbapenem antibiotic during a multi-drug resistant infection cluster

Situation

A national public hospital experienced an acute shortage of a specific carbapenem during a multi-drug resistant infection cluster. Local supply was unavailable for at least three weeks.

Approach

Same-day enquiry response. Identified UK-licensed source with available stock. Prepared EDA import notification documentation alongside the shipment.

Outcome

48-hour delivery to hospital pharmacy. Full GDP chain of custody and batch traceability. A rolling supply arrangement was put in place to bridge the local shortage period.

🕑 ~48 hours from enquiry Service used →
South Asia · India Comparator / Clinical Trial

UK-licensed branded reference product for a Phase III cardiovascular trial

Situation

A CRO running a multi-centre cardiovascular trial required a UK-licensed branded reference product for the comparator arm. Authenticity and chain-of-custody were critical for the regulatory submission.

Approach

Sourced direct from the UK Marketing Authorisation holder. Maintained sealed chain-of-custody from MA holder to trial depot. Provided manufacturer batch records, Certificate of Analysis and licensed distributor declaration.

Outcome

Reference product delivered with a documentation pack suitable for CDSCO and FDA filing. Repeat orders placed for trial continuation.

🕑 Multi-shipment programme Service used →
Sub-Saharan Africa · Kenya NGO / Tender

HIV antiretroviral programme continuity for an international NGO

Situation

An international health NGO running a paediatric ARV programme needed second-source supply when its primary distributor faced an extended outage. Donor compliance required UK-licensed origin.

Approach

Confirmed WHO Prequalification status. Supplied via approved cold chain logistics partner. Provided full institutional procurement documentation including Certificates of Free Sale and Pharmaceutical.

Outcome

Programme continuity maintained over the supply period. KEMSA-compliant import processed cleanly. Donor audit-ready paper trail supplied for the full programme.

🕑 Multi-month programme Service used →
Levant · Lebanon Cold Chain Specialty

Immunosuppressant for a post-transplant patient

Situation

A university medical centre treating a post-transplant patient required a specific immunosuppressant. Local availability was disrupted; cold chain integrity was critical to the supply.

Approach

Sourced from the UK Marketing Authorisation holder. End-to-end 2-8°C cold chain via a Heathrow-validated freight forwarder, with real-time temperature logging throughout.

Outcome

Delivered within 96 hours with a continuous temperature record showing zero excursion. Customs cleared via pre-prepared MoPH documentation. Patient continued on therapy without interruption.

🕑 ~96 hours, zero cold chain excursion Service used →
Europe · Ireland Cross-Border Specialty

Post-Brexit named-patient import supply via the UK-Ireland corridor

Situation

A Dublin teaching hospital required a UK-licensed specialty endocrine product post-Brexit. The existing distributor channel had become commercially unviable for low-volume named-patient import cases.

Approach

Established a direct UK-Ireland export pathway via WDA. Supported the hospital's HPRA notification for its named-patient import. Re-used the same Heathrow-Dublin corridor for routine resupply.

Outcome

5-day end-to-end turnaround on the first order; 48 hours for repeat orders. HPRA-compliant documentation throughout. Ongoing supply relationship for the full patient programme.

🕑 5 days first order, 48h repeats Service used →
How We Approach a New Case

From enquiry to delivered shipment, in four stages.

Every case follows the same four stages, regardless of geography or therapeutic area. The work is in the regulatory framing and the logistics, not the process.

01
Same-day enquiry response
We acknowledge every enquiry within working hours and flag emergency cases for immediate triage. The first response confirms whether the medicine can be sourced and an indicative timeline.
02
Sourcing and regulatory check
We identify authorised manufacturers or distributors, confirm availability, and check destination-country import rules. We will tell you upfront if a route is not viable.
03
Documentation and compliance
Every case is matched to the correct UK regulatory pathway and the destination country's import framework. CoA, batch records, GDP paper trail, export documentation, country-specific permits.
04
Cold chain logistics and delivery
Specialist pharmaceutical freight from Heathrow with full tracking, temperature monitoring where required, and customs clearance support at the destination.

Have a case that does not fit a routine supply chain?

Tell us what you need. We respond the same working day with sourcing options, regulatory feasibility and an honest timeline. No commitment at the enquiry stage.

Submit a Case Enquiry WhatsApp Us Directly
Common Questions
About these case studies.

Direct answers to the obvious questions about anonymisation, references and scope.

Why are these case studies anonymised?
Pharmaceutical procurement is commercially confidential. Hospitals, ministries and NGOs do not authorise the public naming of specific patient supply, tender or programme details, particularly for named-patient imports or locally unregistered medicines. Each case is a composite based on services we routinely operate under WDA(H) 59239.
Can Euro Biom provide direct customer references?
Yes. For active procurement, tender qualification or due diligence, we provide direct references from existing customers under appropriate confidentiality arrangements. Submit your enquiry indicating context, and we will arrange this as part of qualification.
What if our case does not match any of these examples?
These six examples illustrate common patterns but are not exhaustive. We handle named-patient import supply, drug shortage, comparator drugs, supply into overseas managed access programmes, government tender, cold chain shipments, and cross-border specialty supply across more than 40 countries.
How quickly does Euro Biom respond?
Same-day on every working day. Emergency cases within 4 hours. The first response confirms whether the medicine can be sourced, an indicative timeline, and any documentation requirements specific to your destination.
Does Euro Biom supply to my country?
We export to more than 40 countries across the GCC, Levant, North Africa, Sub-Saharan Africa, South and Southeast Asia, CIS, and Europe. Some countries have additional import controls. We assess feasibility at the enquiry stage and will tell you if a route is not viable.
What documentation comes with every supply?
Certificate of Analysis, manufacturer batch records, full GDP chain-of-custody, transport and temperature records where applicable, and all UK export documentation. Country-specific import documentation prepared based on the destination market.
Related resources

Service pages and guides that explain the supply pathways behind each case.

Service
Named-Patient Import Supply
Read the full service page →
Service
Drug Shortage Emergency Supply
View shortage routes →
Service
Comparator Drug Sourcing for Trials
View clinical trial supply →
Service
Cold Chain 2-8°C Pharmaceutical Supply
View cold chain capability →
Service
Tender & Government Pharmaceutical Supply
View tender supply →
Compliance
Our MHRA & GDP Credentials
View regulatory framework →